Dysfunction or abnormalities in the regulation of fatty acid translocase Cd36, a multifunctional membrane protein participating in uptake of long-chain fatty acids, has been linked to the development of heart diseases both in animals and humans. We have previously shown that the Cd36 transgenic spontaneously hypertensive rat (SHR-Cd36), with a wild type Cd36, has higher susceptibility to ischemic ventricular arrhythmias when compared to spontaneously hypertensive rat (SHR) carrying a mutant Cd36 gene, which may have been related to increased β-adrenergic responsiveness of these animals (Neckar et al., 2012 Physiol. Genomics 44:173-182). The present study aimed to determine whether the insertion of the wild type Cd36 into SHR would affect the function of myocardial G protein-regulated adenylyl cyclase (AC) signaling. β-Adrenergic receptors (β-ARs) were characterized by radioligand-binding experiments and the expression of selected G protein subunits, AC, and protein kinase A (PKA) was determined by RT-PCR and Western blot analyses. There was no significant difference in the amount of trimeric G proteins, but the number of β-ARs was higher (by about 35 %) in myocardial preparations from SHR-Cd36 as compared to SHR. Besides that, transgenic rats expressed increased amount (by about 20 %) of the dominant myocardial isoforms AC5/6 and contained higher levels of both nonphosphorylated (by 11 %) and phosphorylated (by 45 %) PKA. Differently stimulated AC activity in SHR-Cd36 significantly exceeded (by about 18-30 %) the enzyme activity in SHR. Changes at the molecular level were reflected by higher contractile responses to stimulation by the adrenergic agonist dobutamine. In summary, it can be concluded that the increased susceptibility to ischemic arrhythmias of SHR-Cd36 is attributable to upregulation of some components of the β-AR signaling pathway, which leads to enhanced sensitization of AC and increased cardiac adrenergic responsiveness.

Department of Cell Biology Faculty of Science Charles University Prague Vinicna 7 128 44 Prague 2 Czech Republic

Zobrazit více v PubMed

Hypertension. 2001 Feb;37(2):209-15 PubMed

Circ Res. 2009 Mar 27;104(6):770-9 PubMed

J Lipid Res. 2009 Apr;50(4):740-8 PubMed

Naunyn Schmiedebergs Arch Pharmacol. 2010 Jul;382(1):63-71 PubMed

Nat Genet. 2001 Feb;27(2):156-8 PubMed

Nucleic Acids Res. 2001 May 1;29(9):e45 PubMed

Trends Pharmacol Sci. 2006 Jun;27(6):330-7 PubMed

Life Sci. 1996;58(2):91-106 PubMed

Prog Pediatr Cardiol. 2011 Jan 1;31(1):35-38 PubMed

J Appl Physiol (1985). 2010 Oct;109(4):1195-202 PubMed

Proc Natl Acad Sci U S A. 2003 May 27;100(11):6819-24 PubMed

Circ Res. 2008 Oct 10;103(8):836-44 PubMed

Circulation. 2004 Mar 30;109(12):1550-7 PubMed

Exp Clin Cardiol. 2011 Fall;16(3):e23-9 PubMed

Can J Physiol Pharmacol. 2000 Mar;78(3):187-98 PubMed

Circ Res. 2001 Nov 23;89(11):997-1004 PubMed

Circulation. 2007 Oct 16;116(16):1776-83 PubMed

Mol Pharmacol. 2001 Sep;60(3):577-83 PubMed

J Hypertens. 2003 Jan;21(1):179-88 PubMed

Circulation. 2000 Apr 11;101(14):1707-14 PubMed

J Biol Chem. 2012 Nov 9;287(46):38901-12 PubMed

Heart Fail Rev. 2009 Dec;14(4):225-41 PubMed

Biochem Pharmacol. 1988 Aug 1;37(15):3017-22 PubMed

Eur J Pharmacol. 2009 Aug 15;616(1-3):1-6 PubMed

Physiol Res. 2008;57(6):973-978 PubMed

J Hypertens. 2011 Apr;29(4):690-5 PubMed

Physiol Genomics. 2012 Feb 1;44(2):173-82 PubMed

Circulation. 2006 Aug 1;114(5):388-96 PubMed

Exp Gerontol. 2009 May;44(5):344-9 PubMed

Basic Res Cardiol. 2010 Mar;105(2):181-92 PubMed

Cardiovasc Res. 2009 Dec 1;84(3):434-41 PubMed

J Pharmacol Exp Ther. 2003 Jul;306(1):1-7 PubMed

Science. 2003 Jun 6;300(5625):1530-2 PubMed

J Muscle Res Cell Motil. 2006;27(5-7):399-403 PubMed

Circulation. 2008 Jan 1;117(1):61-9 PubMed

J Clin Invest. 1995 Oct;96(4):1973-8 PubMed

Jpn Circ J. 1989 Feb;53(2):113-20 PubMed

J Biol Chem. 2001 Jun 29;276(26):23661-6 PubMed

J Mol Med (Berl). 2011 May;89(5):459-69 PubMed

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1607-12 PubMed

Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7059-64 PubMed

Nat Genet. 1997 Jun;16(2):197-201 PubMed

Mol Cell Biochem. 2011 Nov;357(1-2):163-9 PubMed

Blood. 2010 Nov 18;116(20):4297-306 PubMed

Modulation of left ventricular hypertrophy in spontaneously hypertensive rats by acetylcholinesterase and ACE inhibitors: physiological, biochemical, and proteomic studies

Continuous short-term acclimation to moderate cold elicits cardioprotection in rats, and alters β-adrenergic signaling and immune status

Changes in the activity of some metabolic enzymes in the heart of SHR rat incurred by transgenic expression of CD36

β-Adrenergic signaling, monoamine oxidase A and antioxidant defence in the myocardium of SHR and SHR-mtBN conplastic rat strains: the effect of chronic hypoxia

Chronic intermittent hypoxia affects the cytosolic phospholipase A2α/cyclooxygenase 2 pathway via β2-adrenoceptor-mediated ERK/p38 stimulation